| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.003 |